Evidence map›Paper›PMID 39085285›Full record

ArticleScientific reports2024

Effectiveness, reliability, and validity of new Japanese diagnostic criteria for obstetrical disseminated intravascular coagulation.

Mamoru Morikawa, Yoshiharu Takeda, Shigetaka Matsunaga, Shintaro Makino, Eriko Eto, Mariko Serizawa, Masafumi Nii, Jun Takeda, Hisashi Masuyama, Atsuo Itakura

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Observational
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mamoru MorikawaDepartment of Obstetrics and Gynecology, Kansai Medical University, Shinmachi 2-5-1, Hirakata, Osaka, 573-1010, Japan. mmamoru@hirakata.kmu.ac.jp.ORCID 0000-0002-9816-5422
Yoshiharu TakedaDepartment of Obstetrics and Gynecology, Maternal and Child Health Center, Aiiku Hospital, Tokyo, Japan.
Shigetaka MatsunagaDepartment of Obstetrics and Gynecology, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.
Shintaro MakinoDepartment of Obstetrics and Gynecology, Urayasu Hospital, Juntendo University, Urayasu, Chiba, Japan.
Eriko EtoDepartment of Obstetrics and Gynecology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Mariko SerizawaDepartment of Obstetrics and Gynecology, Hamamatsu Medical Center, Hamamatsu, Shizuoka, Japan.
Masafumi NiiDepartment of Obstetrics and Gynecology, Mie University School of Medicine, Tsu, Mie, Japan.
Jun TakedaDepartment of Obstetrics and Gynecology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Hisashi MasuyamaDepartment of Obstetrics and Gynecology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Atsuo ItakuraDepartment of Obstetrics and Gynecology, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since July 2022, obstetrical disseminated intravascular coagulation (DIC) in Japan has been diagnosed based on the new criteria (tentative version), which assesses the main underlying disease, fibrinogen level, and fibrin/fibrinogen degradation products or D-dimer level. In June 2024, the tentative version underwent minor revision and the final version was released. The previous Japanese criteria assessed underlying disease, clinical symptoms, and various laboratory findings. This study aimed to prove the effectiveness, reliability, and validity of the new criteria (final version). We analyzed 212 women with singleton pregnancies who delivered after 22 gestational weeks and experienced blood loss ≥ 1000 mL during vaginal delivery or ≥ 2000 mL during cesarean section. Those with missing laboratory findings before receiving blood transfusion at delivery were excluded. In the obstetrical DIC group, the frequency of fibrinogen levels < 150 mg/dL was significantly higher than in the control group (90% vs. 5%, p < 0.0001), as was the frequency of scores ≥ 8 according to the previous Japanese criteria (100% vs. 10%, p < 0.0001). Cronbach alpha was 0.757 and Spearman's rank-order correlation was 0.558 between the new and previous criteria. In conclusion, we proved the effectiveness, reliability, and validity of the Japanese new criteria (final version) to diagnose obstetrical DIC.

Indexed as

Disseminated Intravascular CoagulationFibrin Fibrinogen Degradation ProductsAdultCesarean SectionEast Asian PeopleFemaleFibrinogenHumansJapanPregnancyPregnancy Complications, HematologicReproducibility of ResultsFibrin Fibrinogen Degradation Productsfibrin fragment DFibrinogenCriteriaObstetrical disseminated intravascular coagulationReliabilityTentative versionValidity

Identifiers

PMID39085285
PMCPMC11291721

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.